AlsterResearch Weekly Screener Page 1 of 6 Weekly Screener 17 May – 24 May 2021, Week 20 Rotation Victims Target Find the stocks that have suffered most from sector rotation. Method Identify the beginning of the sector rotation as the yearly high of the Nasdaq in relation to the Dow Jones Industrial: 12th February 2021. Calculate the stock performance since then and select the companies with the biggest decline. Result from AlsterResearch universe: Rotation Victims Name Performance since start of sector rotation GICS Subsector TeamViewer AG -33,2% Application Software Varta AG -26,9% Electrical Components & Equipment CompuGroup Medical -20,2% Health Care Technology Delivery Hero SE -19,0% Internet & Direct Marketing Retail Formycon AG -18,8% Biotechnology MAKING SENSE OF THE NUMBERS: TeamViewer (AlsterResearch view: BUY / PT EUR 39 / closing price EUR 30,66 / upside 28%) The remote access specialist had to suffer twice: an ill-received marketing partnership with Manchester United AND the rotation out of tech both hurt. Attractive again at current levels. Varta (AlsterResearch view: BUY / PT EUR 130,00 / closing price EUR 116,00 / upside 12%) Varta is translating global market leadership in hearing aid and wireless headset batteries into substantial returns. Sector rotation and a sluggish Q1 could provide a good entry point. CompuGroup Medical (AlsterResearch view: BUY / PT EUR 72,00 / closing price EUR 63,55 / upside 13%) CompuGroup is a provider of software for the healthcare sector. The market currently has decided to treat it as “tech” and not as “health care” and rotate out, probably also as a result of weakish Q1 figures. Delivery Hero (AlsterResearch view: HOLD / PT EUR 130,00 / closing price EUR 103,95 / upside 25%) With a top line growing at stratospheric rates and no earnings in sight, Delivery Hero is the poster child of a growth / tech company, and thus a prime victim when investors are looking for pedestrian valuations. Formycon AG (AlsterResearch view: BUY / PT EUR 80 / closing price EUR 61,40 / upside 31%) As for many research-driven biotech companies, valuation is highly dependent on a few pipeline projects. The extra buzz generated by the development of a treatment for Covid-19 makes Formycon interesting, but volatile. What do you think? Which stock will see the strongest recovery in Q2 and Q3? Take our survey and see what other financial professionals think. Result of last week’s survey Which company deserved the most placings in first 10 weekly screeners? Winner: Hugo Boss AlsterResearch Weekly Screener Page 2 of 6 Result from AlsterResearch universe: Rotation Winners Name Performance since start of sector rotation GICS Subsector Hugo Boss AG 44,6% Apparel, Accessories & Luxury Goods WOLFTANK-ADISA AG 29,7% Environmental & Facilities Services TAKKT AG 24,4% Internet & Direct Marketing Retail Traumhaus AG 18,0% Homebuilding WashTec AG 14,8% Industrial Machinery Looking beyond our coverage: Rotation winners and victims in DAX, MDAX and SDAX DAX: Rotation Victims Name Performance since start of sector rotation GICS Subsector SIEMENS ENERGY AG -22,5% Heavy Electrical Equipment Infineon Technologies AG -13,9% Semiconductors Continental AG -8,7% Auto Parts & Equipment Vonovia SE -8,2% Real Estate Operating Companies RWE AG -7,5% Multi-Utilities DAX: Rotation Winners Name Performance since start of sector rotation GICS Subsector Deutsche Bank AG 29,0% Diversified Capital Markets Volkswagen AG 27,6% Automobile Manufacturers Fresenius SE & Co KGaA 22,0% Health Care Services E.ON SE 21,0% Multi-Utilities LINDE (FRA) 17,7% Industrial Gases MDAX: Rotation Victims Name Performance since start of sector rotation GICS Subsector Shop Apotheke Europe NV -35,5% Internet & Direct Marketing Retail TeamViewer AG -33,2% Application Software MorphoSys AG -30,5% Biotechnology Nordex SE -27,8% Heavy Electrical Equipment Varta AG -26,9% Electrical Components & Equipment MDAX: Rotation Winners Name Performance since start of sector rotation GICS Subsector Hugo Boss AG 44,6% Apparel, Accessories & Luxury Goods CRYPTOLOGY 41,4% Renewable Electricity Porsche Automobil Holding 38,9% Automobile Manufacturers Fraport AG 29,7% Airport Services Commerzbank AG 22,4% Diversified Banks SDAX: Rotation Victims Name Performance since start of sector rotation GICS Subsector home24 SE -40,4% Internet & Direct Marketing Retail SMA Solar Technology AG -29,6% Semiconductor Equipment LPKF Laser & Electronics AG -27,3% Electronic Equipment & Instruments LEONI AG -26,4% Auto Parts & Equipment Hypoport SE -24,8% Other Diversified Financial Services AlsterResearch Weekly Screener Page 3 of 6 SDAX: Rotation Winners Name Performance since start of sector rotation GICS Subsector Wacker Neuson SE 47,9% Construction Machinery & Heavy Trucks Kloeckner & Co SE 29,4% Trading Companies & Distributors TAKKT AG 24,4% Internet & Direct Marketing Retail Salzgitter AG 23,7% Steel 1&1 Drillisch AG 23,6% Wireless Telecommunication Services Sources for all tables: Company data, AlsterResearch, Sentieo AlsterResearch Weekly Screener Page 4 of 6 Conflict of interests Disclosures regarding research publications of SRH AlsterResearch AG pursuant to section 85 of the German Securities Trading Act (WpHG) and distributed in the UK under an EEA branch passport, subject to the FCA requirements on research recommendation disclosures It is essential that any research recommendation is fairly presented and discloses interests of indicates relevant conflicts of interest. Pursuant to section 85 of the German Securities Trading Act (WpHG) a research report has to point out possible conflicts of interest in connection with the analyzed company. Further to this, under the FCA’s rules on research recommendations, any conflicts of interest in connection with the recommendation must be disclosed. A conflict of interest is presumed to exist in particular if SRH AlsterResearch AG (1) or its affiliate(s) (either in its own right or as part of a consortium) within the past twelve months, acquired the financial instruments of the analyzed company, (2) has entered into an agreement on the production of the research report with the analyzed company, (3) or its affiliate(s) has, within the past twelve months, been party to an agreement on the provision of investment banking services with the analyzed company or have received services or a promise of services under the term of such an agreement, (4) or its affiliate(s) holds a) 5% or more of the share capital of the analyzed company, or b) the analyzed company holds 5% or more of the share capital of SRH AlsterResearch AG or its affiliate(s), (5) or its affiliate(s) holds a net long (a) or a net short (b) position of 0.5% of the outstanding share capital of the analyzed company or derivatives thereof, (6) or its affiliate(s) is a market maker or liquidity provider in the financial instruments of the issuer, (7) or the analyst has any other significant financial interests relating to the analyzed company such as, for example, exercising mandates in the interest of the analyzed company or a significant conflict of interest with respect to the issuer, (8) The research report has been made available to the company prior to its publication. Thereafter, only factual changes have been made to the report. Conflicts of interest that existed at the time when this research report was published: Company Disclosure TeamViewer AG None Varta AG None CompuGroup Medical None Delivery Hero SE None Formycon 2 Hugo Boss AG None WOLFTANK-ADISA AG 2 TAKKT AG None Traumhaus AG 2 WashTec AG None AlsterResearch Page 5 of 6 Important disclosures 1. General Information/Liabilities This research report has been produced for The decision on the choice of the financial instruments analyzed in this the information purposes of institutional investors only, and is not in any way document was solely made by SRH AlsterResearch AG. The opinions and a personal recommendation, offer or solicitation to buy or sell the financial estimates in this research report are subject to change without notice. It is instruments mentioned herein. The document is confidential and is made within the discretion of SRH AlsterResearch AG whether and when it publishes available by SRH AlsterResearch AG, exclusively to selected recipients [in DE, an update to this research report, but in general updates are created on a GB, FR, CH, US, UK, Scandinavia, and Benelux or, in individual cases, also in regular basis, after 6 months at the latest. A sensitivity analysis is included other countries]. A distribution to private investors in the sense of the German and published in company’s initial studies. Securities Trading Act (WpHG) is excluded. It is not allowed to pass the research report on to persons other than the intended recipient without the 5. Date and time of first publication of the financial analysis permission of SRH AlsterResearch AG. Reproduction of this document, in May 14, 2021 whole or in part, is not permitted without prior permission SRH AlsterResearch AG. All rights reserved. Under no circumstances shall SRH AlsterResearch AG, 6. Risk information any of its employees involved in the preparation, have any liability for possible • Stock exchange investments and investments in companies (shares) errors or incompleteness of the information included in this research report – are always speculative and involve the risk of total loss. neither in relation to indirect or direct nor consequential damages. Liability for • This is particularly true in respect of investments in companies which damages arising either directly or as a consequence of the use of information, are not established and/or small and have no established business or opinions and estimates is also excluded. Past performance of a financial corporate assets. instrument is not necessarily indicative of future performance. • Share prices may fluctuate significantly. This is particularly true for shares with low liquidity (market breadth). Even small orders can have 2. Responsibilities This research report was prepared by the research analyst a significant impact on the share price.